Kirrhos Pharmaceuticals
Oklahoma City
About Kirrhos Pharmaceuticals
Kirrhos Pharmaceuticals is advancing a novel, “first-in-class” therapeutic to treat a progressive non-alcoholic fatty liver disease
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $850.0K
- Funding stage: Seed
- Last round: Seed (Sep 2019)
Industries & Categories
Pharmaceutical
Canonical: https://fsome.com/organization/kirrhos-pharmaceuticals-2217555 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.